A detailed history of Assetmark, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Assetmark, Inc holds 198,667 shares of BMY stock, worth $11.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
198,667
Previous 172,259 15.33%
Holding current value
$11.2 Million
Previous $7.15 Million 43.73%
% of portfolio
0.03%
Previous 0.02%

Shares

36 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$39.66 - $51.75 $1.05 Million - $1.37 Million
26,408 Added 15.33%
198,667 $10.3 Million
Q2 2024

Aug 13, 2024

SELL
$40.25 - $52.99 $732,348 - $964,153
-18,195 Reduced 9.55%
172,259 $7.15 Million
Q1 2024

May 06, 2024

BUY
$47.98 - $54.4 $1.67 Million - $1.89 Million
34,770 Added 22.33%
190,454 $10.3 Million
Q4 2023

Feb 09, 2024

BUY
$48.48 - $57.85 $743,149 - $886,782
15,329 Added 10.92%
155,684 $7.99 Million
Q3 2023

Oct 27, 2023

BUY
$57.89 - $64.73 $743,654 - $831,521
12,846 Added 10.07%
140,355 $8.15 Million
Q2 2023

Aug 11, 2023

BUY
$63.71 - $70.74 $1 Million - $1.11 Million
15,722 Added 14.06%
127,509 $8.15 Million
Q1 2023

May 05, 2023

BUY
$65.71 - $74.53 $1.73 Million - $1.96 Million
26,270 Added 30.72%
111,787 $7.75 Million
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $1.04 Million - $1.23 Million
15,198 Added 21.61%
85,517 $6.15 Million
Q3 2022

Nov 01, 2022

BUY
$0.13 - $76.84 $3,165 - $1.87 Million
24,352 Added 52.98%
70,319 $5 Million
Q2 2022

Aug 03, 2022

BUY
$72.62 - $79.98 $1.17 Million - $1.29 Million
16,085 Added 53.83%
45,967 $3.54 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $553,688 - $663,922
9,006 Added 43.14%
29,882 $2.18 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $56,418 - $65,771
1,052 Added 5.31%
20,876 $1.3 Million
Q3 2021

Nov 12, 2021

SELL
$59.17 - $69.31 $70,767 - $82,894
-1,196 Reduced 5.69%
19,824 $1.17 Million
Q2 2021

Aug 16, 2021

BUY
$61.91 - $67.42 $4,271 - $4,651
69 Added 0.33%
21,020 $1.41 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $653,214 - $734,673
-11,008 Reduced 34.44%
20,951 $1.32 Million
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $26.7 Million - $30.2 Million
-461,763 Reduced 93.53%
31,959 $1.98 Million
Q3 2020

Nov 13, 2020

BUY
$57.43 - $63.64 $8.86 Million - $9.82 Million
154,295 Added 45.46%
493,722 $29.8 Million
Q2 2020

Aug 11, 2020

BUY
$54.82 - $64.09 $4.54 Million - $5.31 Million
82,876 Added 32.3%
339,427 $19.6 Million
Q1 2020

May 12, 2020

SELL
$46.4 - $67.43 $9.97 Million - $14.5 Million
-214,815 Reduced 45.57%
256,551 $14.3 Million
Q4 2019

Feb 11, 2020

BUY
$49.21 - $64.19 $11.7 Million - $15.3 Million
237,860 Added 101.86%
471,366 $30.3 Million
Q3 2019

Nov 13, 2019

BUY
$42.77 - $50.71 $9.86 Million - $11.7 Million
230,553 Added 7807.42%
233,506 $11.8 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $4,774 - $5,279
107 Added 3.76%
2,953 $134,000
Q1 2019

May 14, 2019

BUY
$45.12 - $53.8 $15,024 - $17,915
333 Added 13.25%
2,846 $136,000
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $54,952 - $71,260
-1,127 Reduced 30.96%
2,513 $131,000
Q3 2018

Nov 13, 2018

SELL
$55.19 - $62.25 $32,065 - $36,167
-581 Reduced 13.76%
3,640 $226,000
Q2 2018

Aug 01, 2018

BUY
$50.53 - $62.98 $24,608 - $30,671
487 Added 13.04%
4,221 $234,000
Q1 2018

May 16, 2018

SELL
$59.92 - $68.98 $140,512 - $161,758
-2,345 Reduced 38.58%
3,734 $236,000
Q4 2017

Feb 13, 2018

BUY
$59.94 - $65.35 $83,556 - $91,097
1,394 Added 29.75%
6,079 $373,000
Q3 2017

Nov 08, 2017

SELL
$55.23 - $63.74 $35.9 Million - $41.5 Million
-650,705 Reduced 99.29%
4,685 $299,000
Q2 2017

Aug 15, 2017

BUY
N/A
55,062 Added 9.17%
655,390 $36.5 Million
Q1 2017

Sep 15, 2017

BUY
N/A
97,374 Added 19.36%
600,328 $32.6 Million
Q4 2016

Sep 15, 2017

BUY
N/A
47,845 Added 10.51%
502,954 $29.4 Million
Q3 2016

Sep 15, 2017

BUY
N/A
452,171 Added 15390.44%
455,109 $24.5 Million
Q2 2016

Sep 15, 2017

SELL
N/A
-283 Reduced 8.79%
2,938 $216,000
Q1 2016

Sep 15, 2017

BUY
N/A
349 Added 12.15%
3,221 $206,000
Q4 2015

Sep 15, 2017

BUY
N/A
2,872
2,872 $198,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Assetmark, Inc Portfolio

Follow Assetmark, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.